Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Etoposide 7Cisplatin 7fludarabine 4Cyclophosphamide 4fludarabine phosphate 3Paclitaxel 3Carboplatin 3Bleomycin 3Automobiles 3pembrolizumab 2etoposide phosphate 2Vorinostat 2Sirolimus 2Mesna 2Ifosfamide 2Drug Therapy 2130-nm albumin-bound paclitaxel 2tremelimumab 1tozuleristide 1sodium thiosulfate 1repotrectinib 1pralsetinib 1pegfilgrastim 1lutetium Lu 177 dotatate 1durvalumab 1cabozantinib 1Watchful Waiting 1Teniposide 1Surveys and Questionnaires 1Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × Teniposide × 1 year × Clear all
NCT07188441 2025-09-23

Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin.

Sun Yat-sen University

Phase 2 Recruiting
40 enrolled

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡